LORI CALL: Open Payments
NPI 1043681265 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 37 payments from 13 companies in 2025. Trend: 2023 $518 · 2024 $230 · 2025 $1,026
Food & beverage: $992Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $310 |
| GENZYME CORPORATION | 2 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $98 |
| Insmed, Inc. | 3 | $74 |
| Grifols USA, LLC | 3 | $69 |
| Amgen Inc. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 3 | $49 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| United Therapeutics Corporation | 1 | $31 |
Products named: DUPIXENT, FASENRA, BREZTRI, Arikayce, Prolastin-C Liquid, NUCALA, OFEV, JASCAYD.
Industry payments across MO — which companies pay providers there.
